Premier Anti-Aging Co., Ltd.

Tokyo Stock Exchange 4934.T

Premier Anti-Aging Co., Ltd. Operating Income for the year ending July 31, 2024: USD 927.13 K

Premier Anti-Aging Co., Ltd. Operating Income is USD 927.13 K for the year ending July 31, 2024, a 121.57% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Premier Anti-Aging Co., Ltd. Operating Income for the year ending July 31, 2023 was USD -4.30 M, a -123.73% change year over year.
  • Premier Anti-Aging Co., Ltd. Operating Income for the year ending July 31, 2022 was USD 18.12 M, a -57.53% change year over year.
  • Premier Anti-Aging Co., Ltd. Operating Income for the year ending July 31, 2021 was USD 42.66 M, a 173.30% change year over year.
  • Premier Anti-Aging Co., Ltd. Operating Income for the year ending July 31, 2020 was USD 15.61 M, a 600.26% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4934.T

Premier Anti-Aging Co., Ltd.

CEO Mr. Kiyoshi Matsuura
IPO Date Oct. 28, 2020
Location Japan
Headquarters Toranomon Hills Mori Tower
Employees 229
Sector Consumer Discretionary
Industries
Description

Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under the DUO and CANADEL brands. It is also involved on the information provision and consulting services related to anti-aging, beauty, and health; research on management and beauty of beauty clinics, etc.; and marketing research and collection and analysis of various information. The company was founded in 2009 and is headquartered in Tokyo, Japan.

Similar companies

4051.T

GMO Financial Gate, Inc.

USD 42.58

1.72%

6027.T

Bengo4.com,Inc.

USD 18.16

0.77%

4565.T

Nxera Pharma Co., Ltd.

USD 6.35

2.58%

4478.T

freee K.K.

USD 22.15

1.37%

StockViz Staff

February 8, 2025

Any question? Send us an email